Workflow
Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of 0.17pershare,beatingtheZacksConsensusEstimateof0.17 per share, beating the Zacks Consensus Estimate of 0.13 per share. This compares to earnings of 0.16pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+30.770.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +30.77%. A quarter ago, it was expected that this pharmaceutical company would post earnings of 0.18 per share when it actually produced earnings of $0.25, delivering a surprise of +38.89%.Over the last fou ...